Literature DB >> 21659525

Tau protein assembles into isoform- and disulfide-dependent polymorphic fibrils with distinct structural properties.

Yoshiaki Furukawa1, Kumi Kaneko, Nobuyuki Nukina.   

Abstract

Tauopathies are neurodegenerative diseases in which insoluble fibrillar aggregates of a microtubule-binding protein, Tau, are abnormally accumulated. Pathological Tau fibrils often exhibit structural polymorphisms that differ among phenotypically distinct tauopathies; however, a molecular mechanism to generate polymorphic Tau fibrils remains obscure. Here, we note the formation of a disulfide bond in isoforms of full-length Tau and show that the thiol-disulfide status as well as the isoform composition determines structural and morphological properties of Tau fibrils in vitro. Mainly two regions in a Tau primary sequence are found to act as structural blocks for building a protease-resistant core of Tau fibrils. Interactions among those two blocks for building a core structure depend upon the thiol-disulfide status in each isoform of Tau, which results in the formation of polymorphic fibrils with distinct structural properties. Furthermore, we have found that more diverse structures of Tau fibrils emerge through a cross-seeded fibrillation between heterologous pairs of Tau isoforms. We thus propose that isoform- and disulfide-dependent combinatorial interactions among multiple regions in a Tau sequence endow Tau fibrils with various structures, i.e. polymorphism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659525      PMCID: PMC3149317          DOI: 10.1074/jbc.M111.248963

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure.

Authors:  M von Bergen; P Friedhoff; J Biernat; J Heberle; E M Mandelkow; E Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 2.  Neurodegenerative tauopathies.

Authors:  V M Lee; M Goedert; J Q Trojanowski
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

3.  Role of cysteine-291 and cysteine-322 in the polymerization of human tau into Alzheimer-like filaments.

Authors:  K Bhattacharya; K B Rank; D B Evans; S K Sharma
Journal:  Biochem Biophys Res Commun       Date:  2001-07-06       Impact factor: 3.575

Review 4.  Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.

Authors:  Gunilla T Westermark; Per Westermark
Journal:  FEBS Lett       Date:  2009-04-23       Impact factor: 4.124

5.  Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias.

Authors:  S Barghorn; Q Zheng-Fischhöfer; M Ackmann; J Biernat; M von Bergen; E M Mandelkow; E Mandelkow
Journal:  Biochemistry       Date:  2000-09-26       Impact factor: 3.162

6.  Mutation-dependent polymorphism of Cu,Zn-superoxide dismutase aggregates in the familial form of amyotrophic lateral sclerosis.

Authors:  Yoshiaki Furukawa; Kumi Kaneko; Koji Yamanaka; Nobuyuki Nukina
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

Review 7.  Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future.

Authors:  Piero Parchi; Rosaria Strammiello; Armin Giese; Hans Kretzschmar
Journal:  Acta Neuropathol       Date:  2010-11-24       Impact factor: 17.088

8.  Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases.

Authors:  Takashi Nonaka; Sayuri T Watanabe; Takeshi Iwatsubo; Masato Hasegawa
Journal:  J Biol Chem       Date:  2010-08-30       Impact factor: 5.157

9.  Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity.

Authors:  Yoko Nekooki-Machida; Masaru Kurosawa; Nobuyuki Nukina; Kazuki Ito; Toshiro Oda; Motomasa Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

10.  C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease.

Authors:  A Abraha; N Ghoshal; T C Gamblin; V Cryns; R W Berry; J Kuret; L I Binder
Journal:  J Cell Sci       Date:  2000-11       Impact factor: 5.285

View more
  26 in total

Review 1.  What is strain in neurodegenerative diseases?

Authors:  Ye Tian; Lanxia Meng; Zhentao Zhang
Journal:  Cell Mol Life Sci       Date:  2019-09-17       Impact factor: 9.261

2.  A 31-residue peptide induces aggregation of tau's microtubule-binding region in cells.

Authors:  Jan Stöhr; Haifan Wu; Mimi Nick; Yibing Wu; Manasi Bhate; Carlo Condello; Noah Johnson; Jeffrey Rodgers; Thomas Lemmin; Srabasti Acharya; Julia Becker; Kathleen Robinson; Mark J S Kelly; Feng Gai; Gerald Stubbs; Stanley B Prusiner; William F DeGrado
Journal:  Nat Chem       Date:  2017-04-03       Impact factor: 24.427

Review 3.  Amyloidogenesis of Tau protein.

Authors:  Bartosz Nizynski; Wojciech Dzwolak; Krzysztof Nieznanski
Journal:  Protein Sci       Date:  2017-09-13       Impact factor: 6.725

4.  Distinct α-synuclein strains differentially promote tau inclusions in neurons.

Authors:  Jing L Guo; Dustin J Covell; Joshua P Daniels; Michiyo Iba; Anna Stieber; Bin Zhang; Dawn M Riddle; Linda K Kwong; Yan Xu; John Q Trojanowski; Virginia M Y Lee
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

5.  The Two Cysteines of Tau Protein Are Functionally Distinct and Contribute Differentially to Its Pathogenicity in Vivo.

Authors:  Engie Prifti; Eleni N Tsakiri; Ergina Vourkou; George Stamatakis; Martina Samiotaki; Katerina Papanikolopoulou
Journal:  J Neurosci       Date:  2020-12-17       Impact factor: 6.167

Review 6.  Potential mechanisms and implications for the formation of tau oligomeric strains.

Authors:  Julia E Gerson; Amrit Mudher; Rakez Kayed
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-09-21       Impact factor: 8.250

7.  In vitro study on the alterations of brain tubulin structure and assembly affected by magnetite nanoparticles.

Authors:  Ali Dadras; Gholam Hossein Riazi; Ali Afrasiabi; Ali Naghshineh; Behafarid Ghalandari; Farzad Mokhtari
Journal:  J Biol Inorg Chem       Date:  2013-02-09       Impact factor: 3.358

8.  A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease.

Authors:  Vega García-Escudero; Daniel Ruiz-Gabarre; Ricardo Gargini; Mar Pérez; Esther García; Raquel Cuadros; Ivó H Hernández; Jorge R Cabrera; Ramón García-Escudero; José J Lucas; Félix Hernández; Jesús Ávila
Journal:  Acta Neuropathol       Date:  2021-05-02       Impact factor: 15.887

9.  Using intramolecular disulfide bonds in tau protein to deduce structural features of aggregation-resistant conformations.

Authors:  Sophie Walker; Orly Ullman; Collin M Stultz
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

Review 10.  The Role of Post-Translational Modifications on the Structure and Function of Tau Protein.

Authors:  Haiqiong Ye; Yue Han; Ping Li; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2022-03-24       Impact factor: 2.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.